B-cell lymphoma medical therapy

B-cell lymphoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating B-cell lymphoma from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
Echocardiography and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Interventions
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
B-cell lymphoma medical therapy On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of B-cell lymphoma medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on B-cell lymphoma medical therapy
CDC on B-cell lymphoma medical therapy
B-cell lymphoma medical therapy in the news
Blogs on B-cell lymphoma medical therapy
Directions to Hospitals Treating B-cell lymphoma
Risk calculators and risk factors for B-cell lymphoma medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Treatment

• Treatment includes radiation and chemotherapy.
• Early-stage indolent B-cell lymphomas can often be treated with radiation alone, with long-term non-recurrence.
• Early-stage aggressive disease is treated with chemotherapy and often radiation, with a 70-90% cure rate.
• Late-stage indolent lymphomas are sometimes left untreated and monitored until they progress.
• Late-stage aggressive disease is treated with chemotherapy, with cure rates of over 70%.

References

Template:WikiDoc Sources